source
- Stealthy startup Treeline plans a reverse mergerLed by former Loxo Oncology CEO Josh Bilenker, the startup now has a trio of cancer drugs in early-stage testing and more following closely behind.BioPharma Dive · 2mo ago↗ source
- FDA Expands Sunscreen Options for the First Time in 20 YearsToday, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency's efforts to advance sunscreen i…fda press · 2mo ago↗ source
- GSK boosts cancer pipeline with $11B Nuvalent buyoutThe British drugmaker's third acquisition this year gives it two experimental lung cancer drugs under FDA review that it hopes will support a franchise.BioPharma Dive